SMTL ID : 6lyy.1

Cryo-EM structure of the human MCT1/Basigin-2 complex in the presence of anti-cancer drug candidate AZD3965 in the outward-open conformation.

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY 3.20 Å

Oligo State

hetero-1-1-mer

Ligands

1 x EY0: 3-methyl-5-[[(4~{R})-4-methyl-4-oxidanyl-1,2-oxazolidin-2-yl]carbonyl]-6-[[5-methyl-3-(trifluoromethyl)-1~{H}-pyrazol-4-yl]methyl]-1-propan-2-yl-thieno[2,3-d]pyrimidine-2,4-dione(Non-covalent)

EY0.1: 17 residues within 4Å: Chain A: Y.34, K.38, L.66, Y.70, M.151, S.154, P.155, L.158, F.274, L.277, F.278, L.281, L.305, D.309, R.313, F.367, S.371 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:Y.34, A:L.66, A:L.158, A:F.278 Hydrogen bonds: A:Y.70, A:S.154, A:D.309, A:R.313, A:R.313, A:S.371 pi-Stacking: A:Y.34, A:F.367

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, N. et al., Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates. Cell (2021)

Release Date

2020-12-23

Peptides

Monocarboxylate transporter 1: A
Basigin: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Monocarboxylate transporter 1

Basigin

Related Entries With Identical Sequence